Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Nature Clinical Practice. Rheumatology|November 1, 2006
Interleukin 6: from bench to bedsideNorihiro Nishimoto, Tadamitsu Kishimoto
Current Opinion in Pharmacology|July 15, 2004
Inhibition of IL-6 for the treatment of inflammatory diseasesNorihiro Nishimoto, Tadamitsu Kishimoto
Arthritis Research|July 12, 2002
The paradigm of IL-6: from basic science to medicineTetsuji Naka, Norihiro Nishimoto, Tadamitsu Kishimoto
Annals of Nuclear Medicine|August 16, 2005
Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibodyKanji Sugimoto, Norihiro Nishimoto, Tadamitsu Kishimoto, et al.
International Journal of Hematology|November 16, 2004
Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemiaAkane Kunitomi, Yoshiteru Konaka, Masato Yagita, et al.
The Journal of Rheumatology|June 2, 2004
Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosisMasahiko Mihara, Masashi Shiina, Norihiro Nishimoto, et al.
Modern Rheumatology|November 4, 2008
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapyNorihiro Nishimoto, Nobuyuki Miyasaka, Kazuhiko Yamamoto, et al.
Arthritis and Rheumatism|June 10, 2003
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritisHideko Nakahara, Jian Song, Masamichi Sugimoto, et al.
Arthritis and Rheumatism|May 27, 2006
Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled studyRainer H Straub, Peter Härle, Seizo Yamana, et al.
Arthritis and Rheumatism|June 10, 2004
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trialNorihiro Nishimoto, Kazuyuki Yoshizaki, Nobuyuki Miyasaka, et al.
Pageof 26